Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Görünümler
• 07/10/23
0
0
gömmek
administrator
Aboneler
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar